πŸ—‚οΈ

Archived grant β€” no longer open

This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.

grant

MuRF1 substrates and mechanisms of skeletal muscle atrophy

Organization OKLAHOMA MEDICAL RESEARCH FOUNDATIONLocation OKLAHOMA CITY, UNITED STATESPosted 1 Apr 2024Deadline 31 Mar 2026 ⚠️
NIHUS FederalResearch GrantFY202520S Catalytic Proteasome20S Core Proteasome20S Proteasome20S ProteosomeAPF-1ATP-Dependent Proteolysis Factor 1AccelerationAffinityAgingAnterior Tibial MuscleAreaAtrophicAtrophyCancersCardiovascular DiseasesCoupledCytoplasmDataDenervationDesminDeuterium OxideDiglycineDiseaseDisorderE3 LigaseE3 Ubiquitin LigaseElectroporationFiberFibroblast Intermediate Filament ProteinsGastrocnemius MuscleGlycyl-GlycineGlycylglycineHMG-20Heavy WaterHigh Mobility Protein 20HindlimbHumanImmobilizationIntermediate Filament ProteinsInvestigationKO miceKidney FailureKidney InsufficiencyKnock-out MiceKnockout MiceKnowledgeL-LysineLabelLengthLinkLiquid ChromatographyLiteratureLysineMacropainMacroxyproteinaseMalignant NeoplasmsMalignant TumorMapsMeasuresMediatingMetabolic Protein DegradationMiceMice MammalsModern ManModificationMulticatalytic ProteinaseMurineMusMuscleMuscle AtrophyMuscle FibersMuscle TissueMuscular AtrophyMyotubesN-GlycylglycineN-glycyl-glycineNerve DegenerationNeuron DegenerationNull MouseOutcomePharmaceutical AgentPharmaceuticalsPharmacologic SubstancePharmacological SubstancePlasmidsPreventionProcessProsomeProteasomeProteasome Endopeptidase ComplexProtein TurnoverProteinsProteomicsProteosomePublicationsRegulatory Protein DegradationRenal FailureRenal InsufficiencyReportingRestRhabdomyocyteRodentRodentiaRodents MammalsRoleSarcomeresScientific PublicationSiteSkeletal FiberSkeletal MuscleSkeletal Muscle CellSkeletal Muscle FiberSkeletal MyocytesSkeletinStriated MusclesTestingThick FilamentTimeTranscriptional ControlTranscriptional RegulationUbiquitinUbiquitin Protein LigaseUbiquitin-Protein Ligase ComplexesUbiquitin-Protein Ligase E3UpregulationValidationVoluntary MuscleWater-d2cardiovascular disorderdevelop therapydrug candidatedrug developmenteffective therapyeffective treatmentelectroporative deliverygastrocnemiusgene electrotransferin vivoinsightintervention developmentmalignancymulticatalytic endopeptidase complexmuscle breakdownmuscle bulkmuscle degradationmuscle deteriorationmuscle formmuscle lossmuscle massmuscle wastingmuscularneoplasm/cancerneural degenerationneurodegenerationneurodegenerativeneurological degenerationneuronal degenerationnew drug targetnew druggable targetnew pharmacotherapy targetnew therapeutic targetnew therapy targetnovelnovel drug targetnovel druggable targetnovel pharmacotherapy targetnovel therapeutic targetnovel therapy targetorthopedic freezingoverexpressoverexpressionpharmaceuticalpreventpreventingprotein degradationresponseselective expressionselectively expressedskeletal muscle atrophyskeletal muscle breakdownskeletal muscle lossskeletal muscle protein lossskeletal muscle wastingsocial roletandem mass spectrometrytherapy developmenttibialis anteriortibialis anterior muscletreatment developmentubiquitin-protein ligasevalidations

Applications closed.

Description preview

SUMMARY
Skeletal muscle atrophy continues to be a serious consequence of many diseases and conditions for which there

is no effective treatment. The E3 ubiquitin ligase, MuRF1 (Trim63), is selectively expressed in striated muscle

and has been shown to be elevated in a myriad of atrophy-inducing conditions in both rodent and human muscle

and thus…

πŸ”’

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link β€” plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial β€” $29.99/mo β†’

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more β€” with email alerts and pipeline tracking.

$29.99 / month

  • πŸ””Email alerts for new matching tenders
  • πŸ—‚οΈTrack tenders in your pipeline
  • πŸ’°Filter by contract value
  • πŸ“₯Export results to CSV
  • πŸ“ŒSave searches with one click
Start 7-day free trial β†’
MuRF1 substrates and mechanisms of skeletal muscle atrophy β€” OKLAHOMA MEDICAL RESEARCH FOUNDATION | UNITED STATES | Apr | Dev Procure